Effect of gemfibrozil on centrifugal behavior of rat peroxisomes and activities of peroxisomal enzymes involved in lipid metabolism

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 4, 1997, Pages 315-321

  Hashimoto, Fumie ^a   Hamada, Seiji ^a   Hayashi, Hidenori ^a  

^a JOSAI UNIVERSITY   (Japan)

Author keywords

cholesterol; clofibric acid; gemfibrozil; HMG CoA reductase; peroxisome

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; ACETYL COENZYME A ACETYLTRANSFERASE; ACID PHOSPHATASE; ACYL COENZYME A DEHYDROGENASE; AMINO ACID OXIDASE; CATALASE; CHOLESTEROL; CLOFIBRIC ACID; CYTOCHROME C OXIDASE; ENOYL COENZYME A HYDRATASE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IOHEXOL; TRIACYLGLYCEROL; TYLOXAPOL; URATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; HYPERLIPIDEMIA; LIVER MICROSOME; MALE; NONHUMAN; PEROXISOME; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030974277     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.315     Document Type: Article

References (45)

1. Cohen B. I., Raicht R. F., Shefer S., Mosbach E. H., Biochim. Biophys. Acta, 369, 79-85 (1974).
2. Berndt J., Garmert R., Still J., Atherosclerosis, 30, 147-152 (1978).
3. Lazarow P. B., de Duve C., Proc. Natl. Acad. Sci. U.S.A., 73, 2043-2046 (1976).
4. Reddy J. K., Lalwani N. D., CRC Crit. Rev. Toxicol., 12, 1-58 (1983).
5. Watanabe T., Mitsukawa M., Horie S., Suga T., Seki K., J. Pharmacobio.-Dyn., 10, 142-147 (1987).
6. Svoboda D. J., Grady H., Azarnoff D. L., J. Cell Biol., 35, 127-152 (1967).
7. Lalwani N. D., Reddy M. K., Qnreshi S. A., Sirtori C. R., Abiko Y., Reddy J. K., Human Toxicol., 2, 27-48 (1983).
8. Maxwell R. E., Nawrocki J. W., Uhlendorf P. D., Atherosclerosis, 48, 195-203 (1983).
9. Gray R. H., de la Iglesia F. A., Hepatotogy, 4, 520-530 (1984).
10. Gorgas K., Krisans S. K., J. Lipid Res., 30, 1859-1875 (1989).
11. Hayashi H., Miwa A., Arch. Biochem. Biophys., 274, 582-589 (1989).
12. Hayashi H., Takahata S., Arch. Biochem. Biophys., 284, 326-331 (1991).
13. Hayashi H., Ohhashi M., Biochim. Biophys. Acta, 1254, 319-325 (1995).
14. Hashimoto F., Ishikawa T., Hamada S., Hayashi H., Biochem. Pharmacol., 49, 1213-1221 (1995).
15. de Duve C., Pressman B. C., Gianetto R., Wattiaux R., Appelman F., Biochem. J., 60, 604-617 (1955).
16. Zlatkis Z., Zak B., Anal. Biochem., 29, 143-148 (1969).
17. Sardesai V. M., Manning J. M., Clin. Chem., 14, 156-161 (1968).
18. Leighton F., Poole B., Beaufay H., Baudhuim P., Coffey L. W., Fowler S., de Duve C., J. Cell Biol., 37, 482-513 (1968).
19. Hayashi H., Suga T., J. Biochem., 84, 513-520 (1978).
20. Hayashi H., Suga T., Niinobe S., Biochem. Biophys. Acta, 252, 58-68 (1971).
21. Hayashi H., Hino S., Yamasaki F., Eur. J. Biochem., 120, 47-51 (1981).
22. Osumi T., Hashimoto T., Biochem. Biophys. Res. Commun., 83, 479-485 (1978).
23. Lazarow P. B., J. Biol. Chem., 253, 1522-1528 (1978).
24. Beaufay H., Amar-Costesec A., Feytmans E., Thines-Sempoux D., Wibo M., Berthet T., J. Cell Biol., 61, 188-200 (1974).
25. Wharton D. C., Tzagolotf A., Meth. Enzymol., 10, 245-250 (1967)
26. Hayashi H., Hino S., Yamasaki F., Watanabe T., Suga T., Biochem. Phamacol., 30, 1817-1822 (1981).
27. Keller G. A., Pazirandeh M., Krisans S., J. Cell Biol., 103, 875-886 (1986).
28. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
29. Bensadoun A., Weistein D., Anal. Biochem., 70, 241-250 (1976).
30. Thorp J. M., Lancet, i, 1323-1326 (1962).
31. Rodney G., Uhlendort P., Maxwell R. E., Proc. Roy. Soc. Med., 69 (Suppl. 2), 6-10 (1976).
32. Dvornik D., Cayen M. N., "Drug Affecting Lipid Metabolism," ed. by Fumagalli R., Kritchevsky D., Paoletti R., Elsevier/North-Holland Biomedical Press, Amsterdam, 1980, pp. 236-272.
33. Krause B. R., Newton R. S., J. Lipid Res., 26, 940-949 (1985).
34. Krause B. R., Newton R. S., Athelosclerosis, 59, 95-98 (1985).
35. Goldfarb S., J. Lipid Res., 19, 489-494 (1978).
36. Erickson S. K., Shrewsbury M. A., Brooks C., Meyer D. J., J. Lipid Res., 21, 930-941 (1980).
37. Kaukola S., Manninen V., Mälkönen M., Ehnholm C., Acta Med. Scand., 209, 69-73 (1981).
38. Shimizu S., Imanaka T., Takano T., Ohkuma S., J. Biochem., 112, 376-384 (1992).
39. Lazalow P. B., de Duve C., Proc. Natl. Acad. Sci. U.S.A., 73, 2043-2046 (1976).
40. Ozasa H., Miyazawa S., Furuta S., Osumi T., Hashimoto T., J. Biochem., 97, 1273-1278 (1985).
41. Keller G.-A., Barton M. C., Shapiro D. J., Singer S. J., Proc. Natl. Acad. Sci. U.S.A., 82, 770-774 (1985).
42. Hashimoto F., Hayashi H., Biochim. Biophys. Acta, 1214, 11-19 (1994).
43. Thompson S. L., Krisans S. K., J. Biol. Chem., 265, 5731-5735 (1990).
44. Okerholm R. A., Keeley F. J., Peterson F. E., Glazko A. J., Proc. Roy. Soc. Med., 69 (Suppl. 2), 11-14 (1976).
45. Endo A., Tsujita Y., Kuroda M., Tanzawa K., Biochim. Biophys. Acta, 575, 266-276 (1979).